Skip to content
In Stock Nitrofurantoin
Antibiotics

Nitrofurantoin

Nitrofurantoin, the active ingredient of Nitrofurantoin, is a urinary antibiotic for adults with uncomplicated lower urinary tract infections. It reaches high concentrations in urine, where it…

Guaranteed quality Original product
Delivery: from 4 days Discreet shipping
24/7 Support Always available
Active ingredient: Nitrofurantoin
Select dosage:
Select pack Package Per unit Price
$ 2.58 $ 258.10
Free Regular Delivery $ 2.19 $ 516.20 $ 437.88 Save 15%
Free Express Delivery $ 2.05 $ 774.30 $ 614.10 Save 21%
Free Express Delivery $ 1.96 $ 1,032.40 $ 784.98 Save 24%
Best value Free Express Delivery $ 1.92 $ 1,290.50 $ 961.20 Save 26%
Free Express Delivery $ 1.93 $ 1,548.60 $ 1,155.22 Save 25%
$ 2.69 $ 268.78
Free Regular Delivery $ 2.24 $ 537.56 $ 448.56 Save 17%
Free Express Delivery $ 2.11 $ 806.34 $ 631.90 Save 22%
Free Express Delivery $ 2.06 $ 1,075.12 $ 822.36 Save 24%
Free Express Delivery $ 2.01 $ 1,343.90 $ 1,005.70 Save 25%
Best value Free Express Delivery $ 1.96 $ 1,612.68 $ 1,176.58 Save 27%

Free delivery on orders from $ 356.00, free express delivery from $ 534.00

Secure payment methods:
VISA AMEX JCB DISCOVER

Nitrofurantoin, the active ingredient of Nitrofurantoin, is a urinary antibiotic for adults with uncomplicated lower urinary tract infections. It reaches high concentrations in urine, where it damages susceptible bacteria while providing limited exposure to tissues outside the urinary tract.

Product information

Nitrofurantoin belongs to the antibacterial class of antibiotics and is used mainly for uncomplicated cystitis, a bacterial infection affecting the bladder. Nitrofurantoin tablets contain the active ingredient and are taken by mouth. The amount taken at each intake is selected individually according to the patient’s age, kidney function, infection pattern, and the specific treatment plan.

Ingredients

The product contains nitrofurantoin as its active ingredient and is supplied as tablets for oral use.

Therapeutic indications

Nitrofurantoin belongs to the antibacterial class of antibiotics and is used mainly for uncomplicated cystitis, a bacterial infection affecting the bladder.

Regulatory and clinical sources from NICE, the EMA, and the FDA support nitrofurantoin among the preferred options for uncomplicated lower urinary tract infection when the likely bacteria are susceptible. It is used against common urinary pathogens, including Escherichia coli, although local resistance patterns and urine-culture results can change the choice of treatment. The medicine is designed for bladder infections rather than infections that have spread into the bloodstream, kidneys, lungs, or other tissues. [1]

Nitrofurantoin can also have a role in recurrent UTI prevention under medical supervision. Preventive treatment uses a different clinical plan from treatment of an active infection, and the dose, duration, and review schedule must be individualised.

Directions for use

  • Dose: The amount taken at each intake is set individually for each person; no single fixed amount is established here.
  • Frequency: Take the tablets at the prescribed frequency; the exact number of times per day is not established here.
  • Timing: Swallow the tablet with food or milk when directed.
  • Duration: Continue treatment for the prescribed duration; the exact course length is not established here.
  • Route: Take by mouth.

When not to use it

Nitrofurantoin is not suitable for everyone. A history of allergy to nitrofurantoin or a previous serious reaction to the drug rules out treatment. Symptoms of a severe allergic reaction include facial or throat swelling, wheezing, widespread rash, faintness, or breathing difficulty.

Severe renal impairment can prevent adequate delivery of nitrofurantoin into urine and may increase systemic exposure. Kidney function should be considered before prescribing, especially in older adults, people with chronic kidney disease, and patients taking several medicines. Australian and European prescribing information uses renal-function thresholds when deciding whether nitrofurantoin is appropriate. [2]

Nitrofurantoin is generally avoided near term and during the final weeks of pregnancy because of a potential risk to the newborn, including haemolysis in susceptible infants. The prescribing decision during pregnancy depends on gestational age, infection severity, bacterial susceptibility, and available alternatives.

When this is not for you

This medication is not for you if:

  • You have had a serious allergic reaction to nitrofurantoin.
  • You have severe kidney impairment or substantially reduced renal function.
  • You have suspected pyelonephritis, with fever, chills, flank pain, or systemic illness.
  • You have a history of nitrofurantoin-related liver injury or serious lung reaction.
  • You are close to delivery or have a newborn with known glucose-6-phosphate dehydrogenase deficiency.
  • You have unexplained urinary symptoms that have not been assessed as a bacterial lower UTI.

Patients with anaemia, diabetes, vitamin B deficiency, lung disease, liver disease, or neurological conditions may need a more careful risk assessment. Long courses require closer review than a short course for acute cystitis.

Reduced kidney function is easy to miss in older adults because serum creatinine can appear only mildly raised. Prescribers often use estimated glomerular filtration rate rather than creatinine alone when assessing nitrofurantoin suitability.

Unwanted effects

Common adverse effects include nausea, reduced appetite, abdominal discomfort, headache, and diarrhoea. Taking the tablet with food or milk can improve gastrointestinal tolerance. Urine may become darker yellow or brown during treatment; this can occur with nitrofurantoin and is not automatically a sign of bleeding.

More serious reactions require urgent medical attention. These include:

  • Shortness of breath, persistent cough, chest discomfort, or fever.
  • Yellowing of the skin or eyes, dark urine with pale stools, or severe upper abdominal discomfort.
  • Tingling, numbness, muscle weakness, or difficulty walking.
  • Widespread rash, blistering, facial swelling, or breathing difficulty.
  • Severe or persistent diarrhoea during or after treatment.
  • Unusual bruising, marked fatigue, or signs of anaemia.

Lung and liver reactions are more associated with prolonged exposure, although acute reactions can occur. Peripheral neuropathy is more likely when risk factors such as renal impairment, diabetes, anaemia, or vitamin deficiency are present. The TGA and EMA product information describe these uncommon but clinically significant reactions. [4]

A mild change in urine colour is different from cola-coloured urine accompanied by jaundice, severe weakness, or abdominal pain. Those additional symptoms need urgent assessment rather than waiting for the course to finish.

Do not take anti-diarrhoeal medicines for severe diarrhoea without checking the cause. Antibiotic-associated colitis can occur after treatment and needs a different response.

Mechanism of action

After oral administration, the kidneys remove nitrofurantoin from the blood and concentrate it in urine. Bacteria exposed to the drug develop damage to several essential cellular processes, including energy production and genetic material. This multi-target activity helps explain why nitrofurantoin remains useful against many common bladder-infection organisms.

The urinary concentration is the key practical feature. Nitrofurantoin achieves antibacterial activity in the urinary tract, while its levels in many other body tissues remain limited. That pharmacokinetic profile makes it suitable for lower urinary tract infection, but unsuitable as the sole treatment for suspected kidney infection or systemic infection.

Common mistakes

Several practical errors can reduce treatment success or increase side effects:

  • Taking doses on an empty stomach despite nausea.
  • Stopping as soon as burning improves.
  • Using leftover tablets for a new episode months later.
  • Taking urinary alkalinisers without checking for an interaction.
  • Assuming darker urine always means bleeding.
  • Ignoring fever or flank pain because the first symptom was bladder discomfort.
  • Crushing tablets when swallowing is difficult without obtaining an appropriate formulation.
  • Taking two doses close together after forgetting one.

If a dose is missed, take it when remembered unless the next scheduled dose is close. Do not double the amount. If repeated missed doses occur, the treatment plan may need clarification because irregular antibiotic exposure can leave symptoms unresolved.

One commonly missed detail is that lower-UTI symptoms and vaginal symptoms can overlap. Itching, unusual discharge, or external soreness may indicate a vaginal condition rather than bladder infection, and nitrofurantoin will not treat those causes.

Another is the difference between prevention and treatment. A preventive regimen may use a lower or less frequent schedule than an acute infection, so an old prescription should not be reused for a new episode.

Comparison

Antibiotic selection depends on the infection site, bacterial susceptibility, kidney function, pregnancy status, allergies, previous cultures, and local resistance data. Nitrofurantoin is narrow in its main clinical role, which helps preserve broader-spectrum antibiotics for infections that require wider tissue penetration.

Antibiotic approach Main strength Main limitation
Nitrofurantoin High urinary concentration for uncomplicated bladder infection Limited usefulness for kidney or systemic infection
Trimethoprim Oral option for susceptible lower UTI Resistance and drug interactions can restrict use
Fluoroquinolone Strong tissue penetration Broader adverse-effect concerns and stewardship limitations

Fluoroquinolones can reach kidney and tissue compartments more effectively than nitrofurantoin, but that advantage is unnecessary for uncomplicated cystitis and can expose patients to avoidable risks. Tendon injury, peripheral neuropathy, central nervous system effects, and disturbances of glucose control are recognised concerns with this antibiotic class.

Trimethoprim may be appropriate when the organism is susceptible and the patient’s medicines and kidney function allow it. Resistance can be substantial in some communities. Nitrofurantoin is favoured for uncomplicated cystitis when appropriate because its urinary activity targets the infection site without relying on a broad systemic spectrum. WHO antibiotic stewardship guidance supports choosing the narrowest suitable option for the diagnosed infection. [3]

Nitrofurantoin is not a suitable choice for every UTI. Fever, rigors, flank pain, low blood pressure, confusion, or vomiting may indicate an infection requiring a different antibiotic strategy and medical assessment.

What doctors say

In clinical practice, doctors usually assess the infection site before selecting nitrofurantoin. A prescription is more appropriate when symptoms point to lower UTI, kidney function is adequate, and there are no signs of systemic illness.

Physicians also look at previous urine cultures. A patient who repeatedly grows bacteria resistant to nitrofurantoin may need a different antibiotic even when the symptoms resemble earlier cystitis. A culture is more valuable after treatment failure, recurrent infection, pregnancy, male UTI, or unusual symptoms.

A doctor will usually expect symptoms such as burning and urinary frequency to begin improving during treatment, though the timing varies. Lack of improvement, deterioration, fever, or new flank pain changes the clinical picture and should trigger reassessment.

Nitrofurantoin is not normally used as a general-purpose antibiotic for chest infections, skin infections, bloodstream infections, or kidney infection. Its benefit depends on reaching an adequate concentration at the site where susceptible bacteria are present.

What customers often ask

Can people under 18 use Nitrofurantoin?

Nitrofurantoin may be prescribed to some children and adolescents when the clinician considers the age, body weight, kidney function, infection site, and formulation. The 2022 WHO AWaRe antibiotic book and TGA product information support age-appropriate prescribing rather than using an adult schedule automatically. Tablets can also be unsuitable for a child who cannot swallow them safely. A paediatric urinary infection may require culture-guided treatment and a liquid formulation. The NHS advises using a formulation that the child can take safely.

What should I do if the expected improvement does not come?

Contact the prescribing service promptly if urinary symptoms do not begin improving, return soon after treatment, or worsen during the course. NICE guidance reviewed in 2024 treats fever, flank pain, vomiting, and systemic illness as reasons to reassess the diagnosis and treatment plan. Nitrofurantoin may be ineffective when the organism is resistant or when the infection has reached the kidneys. Do not compensate by taking extra tablets.

Which condition rules Nitrofurantoin out completely?

A serious previous allergic reaction to nitrofurantoin rules it out. Severe renal impairment is another major restriction because the drug may not reach adequate urinary concentrations and can accumulate in the body. The EMA’s 2018 safety information also identifies suspected upper urinary tract infection as an inappropriate setting for nitrofurantoin alone. A patient with fever and flank pain needs assessment for a deeper infection.

Can alcohol be used while taking Nitrofurantoin?

Alcohol does not have the same specific disulfiram-like interaction associated with some other antibiotics, but it can worsen nausea, dizziness, dehydration, or stomach upset. The 2022 WHO AWaRe antibiotic book supports limiting alcohol when an infection is causing vomiting, poor fluid intake, or systemic symptoms. Heavy alcohol use can also complicate assessment of liver-related symptoms. Avoid alcohol if it makes you feel unwell or prevents adequate hydration.

Can Nitrofurantoin cause diarrhoea?

Yes, diarrhoea can occur because antibiotics alter normal intestinal bacteria. The TGA’s 2023 medicine-safety information recognises gastrointestinal upset as a possible adverse effect, while severe or persistent watery diarrhoea may signal antibiotic-associated colitis. Do not self-treat severe diarrhoea with anti-motility medicines before the cause is assessed. Blood, fever, dehydration, or severe abdominal pain requires prompt attention.

How long does one dose of Nitrofurantoin keep working?

A single dose does not provide a full course of treatment. Nitrofurantoin is cleared through the kidneys and needs repeated administration at the prescribed interval to maintain antibacterial activity in urine. The EMA’s 2018 product information describes schedule-dependent treatment rather than a single long-lasting dose. The prescribed interval should be followed, and missed doses should not be replaced with a double dose.

Do you offer anonymous delivery?

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.

Comparison

Amoxil

Active ingredient: Amoxicillin
250mg 500mg
From $ 138.84
pills
3.7 (3)

Ampicillin

Active ingredient: Ampicillin
250mg 500mg
From $ 142.40
pills
3.7 (5)

Augmentin

Active ingredient: Amoxicillin
1000mg 375mg 625mg
From $ 190.46
pills
3.6 (5)

Bactrim

Active ingredient: Sulfamethoxazole, Trimethoprim
480mg 960mg
From $ 165.54
pills
3.5 (5)

Ciplox

Active ingredient: Ciprofloxacin
500mg 250mg
From $ 142.40
pills
3.7 (3)

Cipro

Active ingredient: Ciprofloxacin
250mg 500mg 750mg
From $ 179.78
pills
3.9 (5)

How the medicines for Antibiotics compare

Available Pharmaceutical Formulations

Nitrofurantoin is available internationally in several oral forms, including tablets, capsules, modified-release capsules, and oral liquid preparations. The product on this page is supplied as oral tablets containing 100 mg of nitrofurantoin.

Different formulations are not automatically interchangeable. Modified-release products may release the active ingredient over a different period, while macrocrystalline formulations can be selected when gastrointestinal tolerance is a concern. The prescriber or dispensing pharmacist determines whether a particular formulation suits the treatment plan.

Formulation type Practical distinction Typical clinical use
Immediate-release tablet Releases nitrofurantoin after swallowing Treatment plans for susceptible lower UTI
Macrocrystalline capsule or tablet Crystal structure may affect gastrointestinal tolerance Lower UTI when this formulation is selected
Modified-release oral form Releases the drug over a longer interval Selected dosing schedules for lower UTI

Several international brand names exist for nitrofurantoin products, but the clinically relevant information is the active ingredient, strength, formulation, and prescribed schedule. Nitrofurantoin tablets should not be substituted casually for a modified-release or liquid preparation.

Sources

  1. NICE (2024). Urinary tract infection (lower): antimicrobial prescribing, NG109.
  2. EMA (2018). Nitrofurantoin-containing medicinal products: referral under Article 31 of Directive 2001/83/EC.
  3. WHO (2022). The WHO AWaRe (Access, Watch, Reserve) antibiotic book.
  4. Therapeutic Goods Administration (2023). Nitrofurantoin: Australian product information.

How Buyers Rate Nitrofurantoin

Based on 3 reviews

Michael N., 52 Verified
Rating: 5 out of 5

took the prescribed 100 mg tablets with meals for a bladder infection. Nausea was noticeable on the first day but settled when he stopped taking the tablets on an empty stomach. Burning improved within a few days, and he completed the course.

16 Nov 2026
James, 26 Verified
Rating: 3.5 out of 5

used nitrofurantoin for uncomplicated cystitis and found the tablets easy to take. He expected immediate relief, became concerned after the first day, and later learned that the symptoms needed more time to improve. A mild headache was the only problem he described.

18 Oct 2026
Andrew, 45 Verified
Rating: 2 out of 5

developed worsening discomfort and a fever while taking the medicine. The treatment did not control the infection because the illness needed reassessment and a different clinical approach. He later reported that the important warning sign had been the fever, not the urinary frequency.

2 Nov 2026
Get our free app Shop faster and track your orders 3.8 · 494 reviews Install